02:31:18 EST Fri 30 Jan 2026
Enter Symbol
or Name
USA
CA



Rakovina Therapeutics Inc (2)
Symbol RKV
Shares Issued 21,148,039
Close 2026-01-29 C$ 0.18
Market Cap C$ 3,806,647
Recent Sedar+ Documents

Rakovina Therapeutics debentures extended

2026-01-29 21:49 ET - Private Placement - Debenture

Further to the convertible debentures issued pursuant to a private placement originally accepted by the TSX Venture Exchange on June 14, 2023, as amended on Dec. 4, 2025, the exchange has consented to an amendment of the original convertible debentures. The company is not receiving any new additional funds.

Original convertible debentures -- maturity date:  Jan. 28, 2026

Amended convertible debentures -- maturity date:  March 11, 2026

The amount of aggregate principal outstanding is $1,454,000. All other details of the amended convertible debentures remain unchanged from the original convertible debentures.

For further information, please refer to the company's news releases dated June 30, 2025, Nov. 28, 2025, and Jan. 27, 2026.

© 2026 Canjex Publishing Ltd. All rights reserved.